Literature DB >> 12884294

Human NK cells express Fc receptors for IgA which mediate signal transduction and target cell killing.

Gabriela Mota1, Mioara Manciulea, Ecaterina Cosma, Iulia Popescu, Mirela Hirt, Erika Jensen-Jarolim, Ana Calugaru, Cecilia Galatiuc, Teodor Regalia, Dietmar Tamandl, Andreas Spittler, George Boltz-Nitulescu.   

Abstract

Receptors for the Fc region of IgG (FcgammaRIIIa, FcgammaRIIc) and IgM (FcmicroR) were previously described on NK cells. In this work the expression of Fc receptors for IgA (FcalphaR) on human NK cells and the signaling events were investigated. The FcalphaR was demonstrated by flow cytometry using secretory IgA (sIgA) and anti-human IgA antibody. The percentage of NK cells (CD3(-)CD56(+)CD16(+)) expressing FcalphaR ranged between 55.7% and 95.7%, with a mean +/- SD of 75.2+/-11.8. The association constant and the number of (125)I-labeled sIgA ((125)I-sIgA) molecules bound per cell, calculated by Scatchard analysis, were 2 x 10(7) M(-1) and 1.7 x 10(4), respectively. The binding specificity was proved by inhibition experiments. Cold sIgA but not IgA Fab fragments were able to inhibit (125)I-sIgA binding in a concentration-dependent manner. Binding of sIgA to NK cells was neither inhibited by anti-mannose receptor antibody, nor by L-fucose, D-galactose, D-glucose, D-mannose or N-acetyl-D-glucosamine. Pretreatment of NK cells with polymeric IgA inhibited their capacity to kill (51)Cr-labeled K562 target cells by 34.8%, whereas with monomeric IgA only by 13.1%. Ligand-induced clustering of the FcalphaR resulted in activation of tyrosine kinases Lck, Syk and phosphatidylinositol 3-kinase. The present studies support the concept that human NK cells bind preferentially sIgA and polymeric IgA with moderate affinity via FcalphaR, which is different from the FcalphaRI/CD89 and other carbohydrate-recognizing receptors like mannose receptor/CD206. This novel structure mediates signal transduction and cell killing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884294     DOI: 10.1002/eji.200323534

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

2.  In silico modeling of pH-optimum of protein-protein binding.

Authors:  Rooplekha C Mitra; Zhe Zhang; Emil Alexov
Journal:  Proteins       Date:  2010-12-22

3.  Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.

Authors:  S L Surman; B G Jones; R E Sealy; R Rudraraju; J L Hurwitz
Journal:  Vaccine       Date:  2014-03-21       Impact factor: 3.641

4.  Induction of IgM, IgA and IgE antibodies in colorectal cancer patients vaccinated with a recombinant CEA protein.

Authors:  Caroline Staff; Carl G M Magnusson; Mohammad Hojjat-Farsangi; Szilvia Mosolits; Maria Liljefors; Jan-Erik Frödin; Britta Wahrén; Håkan Mellstedt; Gustav J Ullenhag
Journal:  J Clin Immunol       Date:  2012-03-02       Impact factor: 8.317

Review 5.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

6.  Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Authors:  Diego A Vargas-Inchaustegui; Marjorie Robert-Guroff
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

7.  The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19).

Authors:  Jianguo Shi; Richard S McIntosh; Jaime Adame-Gallegos; Prabhjyot K Dehal; Marjolein van Egmond; Jan van de Winkel; Simon J Draper; Emily K Forbes; Patrick H Corran; Anthony A Holder; Jenny M Woof; Richard J Pleass
Journal:  BMC Biotechnol       Date:  2011-07-22       Impact factor: 2.563

8.  Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant.

Authors:  Fengmin Zhou; Amanda Goodsell; Yasushi Uematsu; Michael Vajdy
Journal:  Clin Vaccine Immunol       Date:  2009-02-04

9.  Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection.

Authors:  Martin R Goodier; Ana Rodriguez-Galan; Chiara Lusa; Carolyn M Nielsen; Alansana Darboe; Ana L Moldoveanu; Matthew J White; Ron Behrens; Eleanor M Riley
Journal:  J Immunol       Date:  2016-05-27       Impact factor: 5.422

10.  Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.

Authors:  María Julia Ruiz; Yanina Ghiglione; Juliana Falivene; Natalia Laufer; María Pía Holgado; María Eugenia Socías; Pedro Cahn; Omar Sued; Luis Giavedoni; Horacio Salomón; María Magdalena Gherardi; Ana María Rodríguez; Gabriela Turk
Journal:  J Virol       Date:  2016-01-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.